Emodin has been demonstrated to prevent severe acute pancreatitis-associated acute lung injury by upregulating the expression of Nrf2 and HO-1 in a dose-dependent manner, as evidenced in both animal models and cell cultures. The gene discussed is HMOX1; the disease is acute pancreatitis.